Brii Biosciences
PublicLast Round
IPO Announced
Jul 13, 2021
Est. Valuation
$2.06B
Total Funding Raised
$731.93M
Company Overview
Brii Biosciences is a biotechnology company dedicated to advancing therapies for infectious diseases and CNS disorders, with a pipeline of over 10 product candidates targeting significant public health challenges.
Sector
Biotech
AI Layer
Non-AI
Keywords
Hepatitis B (HBV) functional cure programHBV combination therapydrug in-licensing and co-development modelHBV-targeting siRNA therapeuticdrug commercialization for Greater Chinatherapeutics for central nervous system (CNS) disordersnovel antibiotic for gram-negative infectionsHBV neutralizing monoclonal antibodyHBV therapeutic vaccinelong-acting injectable for anxiety and depressionpostpartum depression therapeuticCOVID-19 neutralizing antibody therapyclinical-stage biopharmaceutical company
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brii Biosciences Comps
Public and private peers based on sector, stage, and business model.
Brii Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Jul 13, 2021 | ||||
| Series C | Mar 23, 2021 | ||||
| Series B | Dec 27, 2019 | ||||
| Series A | Jun 22, 2018 |
Brii Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boyu Capital | Series A, Series B |
| Lake Bleu Capital | Series C |
| OppenheimerFunds | Series C |
| RBC Global Asset Management (Asia) Limited | IPO |
| Blue Pool Capital | Series A, Series B |
| The Valliance Fund | IPO |
| China International Capital Corporation | IPO |
Brii Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersBeijing, Beijing
Employee Range86
Year Founded2018
Last FundingJul 13, 2021
